Duyuru • Apr 14
Pakistan Oxygen Limited to Report Q1, 2026 Results on Apr 27, 2026 Pakistan Oxygen Limited announced that they will report Q1, 2026 results on Apr 27, 2026 Reported Earnings • Apr 12
Full year 2025 earnings released: EPS: PK₨19.16 (vs PK₨8.17 in FY 2024) Full year 2025 results: EPS: PK₨19.16 (up from PK₨8.17 in FY 2024). Revenue: PK₨13.0b (up 15% from FY 2024). Net income: PK₨1.67b (up 135% from FY 2024). Profit margin: 13% (up from 6.3% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth. Reported Earnings • Mar 04
Full year 2025 earnings released: EPS: PK₨19.16 (vs PK₨8.17 in FY 2024) Full year 2025 results: EPS: PK₨19.16 (up from PK₨8.17 in FY 2024). Revenue: PK₨13.0b (up 15% from FY 2024). Net income: PK₨1.67b (up 135% from FY 2024). Profit margin: 13% (up from 6.3% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth. Duyuru • Mar 03
Pakistan Oxygen Limited, Annual General Meeting, Apr 27, 2026 Pakistan Oxygen Limited, Annual General Meeting, Apr 27, 2026. Location: west wharf, dockyard road, karachi Pakistan Duyuru • Feb 14
Pakistan Oxygen Limited to Report Fiscal Year 2025 Results on Feb 27, 2026 Pakistan Oxygen Limited announced that they will report fiscal year 2025 results on Feb 27, 2026 Duyuru • Jan 30
Pakistan Oxygen Limited Announces Directorate Changes, Effective January 30, 2026 Pakistan Oxygen Limited elected directors at the extra ordinary genera meeting for a term of 3 years commencing from Janaury 30, 2026. Mr. Muhammad Ashraf Bawany, Mr. Arshad Mohsin Tayebaly Ms. Sadia Khan, Mrs. Saadia Naveed, Mr. Sohail Razi Khan. Valuation Update With 7 Day Price Move • Nov 13
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to PK₨333, the stock trades at a trailing P/E ratio of 16.4x. Average trailing P/E is 11x in the Chemicals industry in Pakistan. Total returns to shareholders of 226% over the past three years. Valuation Update With 7 Day Price Move • Oct 30
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to PK₨279, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 11x in the Chemicals industry in Pakistan. Total returns to shareholders of 179% over the past three years. Duyuru • Oct 15
Pakistan Oxygen Limited to Report Q3, 2025 Results on Oct 24, 2025 Pakistan Oxygen Limited announced that they will report Q3, 2025 results on Oct 24, 2025 Reported Earnings • Aug 29
Second quarter 2025 earnings released: EPS: PK₨5.85 (vs PK₨1.52 in 2Q 2024) Second quarter 2025 results: EPS: PK₨5.85 (up from PK₨1.52 in 2Q 2024). Revenue: PK₨3.12b (up 13% from 2Q 2024). Net income: PK₨510.1m (up 285% from 2Q 2024). Profit margin: 16% (up from 4.8% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 37% per year whereas the company’s share price has increased by 34% per year. New Risk • Aug 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Pakistani stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.6x net interest cover). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Market cap is less than US$100m (PK₨21.1b market cap, or US$74.6m). Valuation Update With 7 Day Price Move • Jun 27
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to PK₨183, the stock trades at a trailing P/E ratio of 17.2x. Average trailing P/E is 11x in the Chemicals industry in Pakistan. Total returns to shareholders of 95% over the past three years. Reported Earnings • Apr 28
First quarter 2025 earnings released: EPS: PK₨4.49 (vs PK₨2.05 in 1Q 2024) First quarter 2025 results: EPS: PK₨4.49 (up from PK₨2.05 in 1Q 2024). Revenue: PK₨2.95b (up 8.1% from 1Q 2024). Net income: PK₨391.5m (up 119% from 1Q 2024). Profit margin: 13% (up from 6.5% in 1Q 2024). Over the last 3 years on average, earnings per share has increased by 14% per year whereas the company’s share price has increased by 12% per year. Valuation Update With 7 Day Price Move • Apr 22
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to PK₨161, the stock trades at a trailing P/E ratio of 19.7x. Average trailing P/E is 9x in the Chemicals industry in Pakistan. Total returns to shareholders of 50% over the past three years. Duyuru • Mar 03
Pakistan Oxygen Limited, Annual General Meeting, Apr 24, 2025 Pakistan Oxygen Limited, Annual General Meeting, Apr 24, 2025. Location: at the company`s registered office, west wharf, dockyard road, karachi Pakistan Duyuru • Mar 01
Pakistan Oxygen Limited Appoints Asad Said Jafar as Independent Director Pakistan Oxygen Limited has announced the appointment of Mr. Asad Said Jafar as an Independent Director, succeeding Mr. Atif Aslam Bajwa. The decision was made during the company's Board of Directors meeting held on February 27, 2025. The appointment is effective immediately, from February 27, 2025. The Board of Directors has made this strategic appointment to ensure continued governance and oversight within the company. The company has not disclosed further details regarding the future direction or priorities under the new directorship, and it remains to be seen how Mr. Jafar's leadership will influence the company's trajectory. Reported Earnings • Oct 29
Third quarter 2024 earnings released: EPS: PK₨1.68 (vs PK₨0.07 in 3Q 2023) Third quarter 2024 results: EPS: PK₨1.68 (up from PK₨0.07 in 3Q 2023). Revenue: PK₨2.78b (up 17% from 3Q 2023). Net income: PK₨146.3m (up PK₨141.0m from 3Q 2023). Profit margin: 5.3% (up from 0.2% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings. Duyuru • Oct 18
Pakistan Oxygen Limited Appoints Jamshed Azhar as the Chief Financial Officer Pakistan Oxygen Limited has officially appointed Mr. Jamshed Azhar as the Chief Financial Officer (CFO) of the company, effective from October 14, 2024. The letter was signed by Maqsoor Iqbal, the Company Secretary of Pakistan Oxygen Limited, who expressed the board's confidence in Mr. Azhar's capabilities to steer the financial operations of the company. The communication also instructed that the TRE Certificate Holders of the exchange be informed of this significant change in the company's leadership. This decision comes as part of Pakistan Oxygen's ongoing enhancements to its executive team, aiming to strengthen its market position and operational efficiency. Mr. Azhar brings extensive experience in financial management, which is anticipated to be vital as the company continues to expand and adapt to the dynamic market demands. New Risk • Aug 26
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Pakistani stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.5x net interest cover). Earnings have declined by 3.8% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Profit margins are more than 30% lower than last year (3.1% net profit margin). Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (PK₨9.69b market cap, or US$34.8m). Valuation Update With 7 Day Price Move • Aug 21
Investor sentiment improves as stock rises 25% After last week's 25% share price gain to PK₨113, the stock trades at a trailing P/E ratio of 34.1x. Average trailing P/E is 7x in the Chemicals industry in Pakistan. Total returns to shareholders of 21% over the past three years. Duyuru • Jun 27
Pakistan Oxygen Limited Announces Appointment of Nadir Salar Qureshi as Independent Director Pakistan Oxygen Limited has officially appointed Mr. Nadir Salar Qureshi as an Independent Director, effective from June 20, 2024. This decision, taken through a resolution passed by circulation, sees Mr. Qureshi stepping into the role formerly held by Mr. Jahangir Piracha. Reported Earnings • May 02
First quarter 2024 earnings released: EPS: PK₨2.05 (vs PK₨0.46 in 1Q 2023) First quarter 2024 results: EPS: PK₨2.05 (up from PK₨0.46 in 1Q 2023). Revenue: PK₨2.73b (up 50% from 1Q 2023). Net income: PK₨178.4m (up 436% from 1Q 2023). Profit margin: 6.5% (up from 1.8% in 1Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. New Risk • Apr 11
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 26% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Earnings have declined by 3.7% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.7% net profit margin). Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (PK₨6.93b market cap, or US$24.9m). Reported Earnings • Apr 04
Full year 2023 earnings released: EPS: PK₨1.66 (vs PK₨5.74 in FY 2022) Full year 2023 results: EPS: PK₨1.66 (down from PK₨5.74 in FY 2022). Revenue: PK₨8.59b (up 18% from FY 2022). Net income: PK₨144.7m (down 66% from FY 2022). Profit margin: 1.7% (down from 5.8% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Nov 28
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to PK₨105, the stock trades at a trailing P/E ratio of 49x. Average trailing P/E is 6x in the Chemicals industry in Pakistan. Total returns to shareholders of 33% over the past three years. New Risk • Nov 10
New major risk - Revenue and earnings growth Earnings have declined by 0.1% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.3x net interest cover). Earnings have declined by 0.1% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Profit margins are more than 30% lower than last year (2.0% net profit margin). Market cap is less than US$100m (PK₨6.54b market cap, or US$22.8m). Reported Earnings • Nov 01
Third quarter 2023 earnings released: EPS: PK₨0.53 (vs PK₨1.33 in 3Q 2022) Third quarter 2023 results: EPS: PK₨0.53 (down from PK₨1.33 in 3Q 2022). Revenue: PK₨6.07b (up 236% from 3Q 2022). Net income: PK₨39.0m (down 60% from 3Q 2022). Profit margin: 0.6% (down from 5.4% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Sep 08
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to PK₨85.79, the stock trades at a trailing P/E ratio of 25.2x. Average trailing P/E is 7x in the Chemicals industry in Pakistan. Total loss to shareholders of 2.1% over the past three years. New Risk • Sep 02
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 3.4% Last year net profit margin: 6.0% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). High level of non-cash earnings (34% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (3.4% net profit margin). Market cap is less than US$100m (PK₨5.30b market cap, or US$17.3m). Reported Earnings • Sep 02
Second quarter 2023 earnings released: EPS: PK₨0.01 (vs PK₨1.15 in 2Q 2022) Second quarter 2023 results: EPS: PK₨0.01 (down from PK₨1.15 in 2Q 2022). Revenue: PK₨1.88b (down 2.9% from 2Q 2022). Net income: PK₨413.0k (down 100% from 2Q 2022). Profit margin: 0% (down from 4.4% in 2Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Apr 13
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to PK₨125, the stock trades at a trailing P/E ratio of 17.4x. Average trailing P/E is 8x in the Chemicals industry in Pakistan. Total returns to shareholders of 50% over the past three years. Reported Earnings • Apr 06
Full year 2022 earnings released: EPS: PK₨7.17 (vs PK₨7.70 in FY 2021) Full year 2022 results: EPS: PK₨7.17 (down from PK₨7.70 in FY 2021). Revenue: PK₨7.30b (up 4.2% from FY 2021). Net income: PK₨420.1m (down 6.9% from FY 2021). Profit margin: 5.8% (down from 6.4% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 23% per year whereas the company’s share price has increased by 22% per year. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 7 non-independent directors. Independent Director Mohammad Dagha was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 30
Third quarter 2022 earnings released: EPS: PK₨1.66 (vs PK₨2.18 in 3Q 2021) Third quarter 2022 results: EPS: PK₨1.66 (down from PK₨2.18 in 3Q 2021). Revenue: PK₨1.81b (flat on 3Q 2021). Net income: PK₨97.4m (down 24% from 3Q 2021). Profit margin: 5.4% (down from 7.1% in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 17% per year. Duyuru • Oct 27
Pakistan Oxygen Limited Appoints Mohammad Iqbal Puri as Director Pakistan Oxygen Limited announced that Mr. Mohammad Iqbal Puri has been appointed as Director of the company with effect from October 25, 2022 in place of Mr. Shahid Abdul Sattar. Reported Earnings • Sep 01
Second quarter 2022 earnings released: EPS: PK₨1.44 (vs PK₨1.90 in 2Q 2021) Second quarter 2022 results: EPS: PK₨1.44 (down from PK₨1.90 in 2Q 2021). Revenue: PK₨1.94b (down 4.4% from 2Q 2021). Net income: PK₨84.5m (down 24% from 2Q 2021). Profit margin: 4.4% (down from 5.5% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • May 01
First quarter 2022 earnings released: EPS: PK₨2.56 (vs PK₨1.85 in 1Q 2021) First quarter 2022 results: EPS: PK₨2.56 (up from PK₨1.85 in 1Q 2021). Revenue: PK₨1.83b (up 20% from 1Q 2021). Net income: PK₨120.2m (up 11% from 1Q 2021). Profit margin: 6.6% (down from 7.1% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 16% per year. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 7 non-independent directors. Independent Director Mohammad Dagha was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Apr 06
Full year 2021 earnings released: EPS: PK₨9.62 (vs PK₨7.39 in FY 2020) Full year 2021 results: EPS: PK₨9.62 (up from PK₨7.39 in FY 2020). Revenue: PK₨7.01b (up 26% from FY 2020). Net income: PK₨451.1m (up 30% from FY 2020). Profit margin: 6.4% (up from 6.2% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 13% per year. Reported Earnings • Oct 29
Third quarter 2021 earnings released: EPS PK₨2.73 (vs PK₨2.66 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: PK₨1.81b (up 3.2% from 3Q 2020). Net income: PK₨128.1m (up 2.9% from 3Q 2020). Profit margin: 7.1% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 9% per year. Reported Earnings • Aug 31
Second quarter 2021 earnings released: EPS PK₨2.38 (vs PK₨0.51 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: PK₨2.03b (up 86% from 2Q 2020). Net income: PK₨111.4m (up 366% from 2Q 2020). Profit margin: 5.5% (up from 2.2% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 11% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • May 05
Investor sentiment deteriorated over the past week After last week's 16% share price decline to PK₨150, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 8x in the Chemicals industry in Pakistan. Total returns to shareholders of 23% over the past three years. Reported Earnings • May 01
First quarter 2021 earnings released: EPS PK₨2.78 (vs PK₨0.35 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: PK₨1.52b (up 27% from 1Q 2020). Net income: PK₨108.7m (up PK₨92.0m from 1Q 2020). Profit margin: 7.1% (up from 1.4% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment deteriorated over the past week After last week's 15% share price decline to PK₨135, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 10x in the Chemicals industry in Pakistan. Total loss to shareholders of 9.4% over the past three years. Is New 90 Day High Low • Mar 11
New 90-day low: PK₨146 The company is down 8.0% from its price of PK₨159 on 11 December 2020. The Pakistani market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period. Reported Earnings • Mar 02
Full year 2020 earnings released: EPS PK₨8.87 (vs PK₨7.70 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2020 results: Revenue: PK₨5.55b (up 19% from FY 2019). Net income: PK₨346.3m (up 15% from FY 2019). Profit margin: 6.2% (down from 6.4% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Jan 12
New 90-day high: PK₨173 The company is up 16% from its price of PK₨149 on 14 October 2020. The Pakistani market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. Reported Earnings • Oct 22
Third quarter earnings released Over the last 12 months the company has reported total profits of PK₨195.7m, down 47% from the prior year. Total revenue was PK₨5.17b over the last 12 months, up 8.4% from the prior year. Is New 90 Day High Low • Sep 24
New 90-day low: PK₨153 The company is down 10.0% from its price of PK₨170 on 26 June 2020. The Pakistani market is up 22% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. 
